These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
110 related articles for article (PubMed ID: 21492075)
1. Neuropilin and neuropilin associated molecules as new molecular targets in pancreatic adenocarcinoma. Muders MH Anticancer Agents Med Chem; 2011 Jun; 11(5):442-7. PubMed ID: 21492075 [TBL] [Abstract][Full Text] [Related]
2. Silencing of Neuropilins and GIPC1 in pancreatic ductal adenocarcinoma exerts multiple cellular and molecular antitumor effects. Borchardt H; Schulz A; Datta K; Muders MH; Aigner A Sci Rep; 2019 Oct; 9(1):15471. PubMed ID: 31664117 [TBL] [Abstract][Full Text] [Related]
3. Neuropilins in tumor biology. Bagri A; Tessier-Lavigne M; Watts RJ Clin Cancer Res; 2009 Mar; 15(6):1860-4. PubMed ID: 19240167 [TBL] [Abstract][Full Text] [Related]
4. Structural and functional relation of neuropilins. Nakamura F; Goshima Y Adv Exp Med Biol; 2002; 515():55-69. PubMed ID: 12613543 [TBL] [Abstract][Full Text] [Related]
5. Neuropilin-1 (NRP-1)/GIPC1 pathway mediates glioma progression. Zhang G; Chen L; Sun K; Khan AA; Yan J; Liu H; Lu A; Gu N Tumour Biol; 2016 Oct; 37(10):13777-13788. PubMed ID: 27481513 [TBL] [Abstract][Full Text] [Related]
6. The interaction of Neuropilin-1 and Neuropilin-2 with tyrosine-kinase receptors for VEGF. Neufeld G; Kessler O; Herzog Y Adv Exp Med Biol; 2002; 515():81-90. PubMed ID: 12613545 [TBL] [Abstract][Full Text] [Related]
7. Pancreatic carcinoma cells express neuropilins and vascular endothelial growth factor, but not vascular endothelial growth factor receptors. Li M; Yang H; Chai H; Fisher WE; Wang X; Brunicardi FC; Yao Q; Chen C Cancer; 2004 Nov; 101(10):2341-50. PubMed ID: 15476280 [TBL] [Abstract][Full Text] [Related]
8. A novel association of neuropilin-1 and MUC1 in pancreatic ductal adenocarcinoma: role in induction of VEGF signaling and angiogenesis. Zhou R; Curry JM; Roy LD; Grover P; Haider J; Moore LJ; Wu ST; Kamesh A; Yazdanifar M; Ahrens WA; Leung T; Mukherjee P Oncogene; 2016 Oct; 35(43):5608-5618. PubMed ID: 26804176 [TBL] [Abstract][Full Text] [Related]
9. Neuropilin-1 and neuropilin-2 enhance VEGF121 stimulated signal transduction by the VEGFR-2 receptor. Shraga-Heled N; Kessler O; Prahst C; Kroll J; Augustin H; Neufeld G FASEB J; 2007 Mar; 21(3):915-26. PubMed ID: 17185751 [TBL] [Abstract][Full Text] [Related]
10. Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors. Gray MJ; Wey JS; Belcheva A; McCarty MF; Trevino JG; Evans DB; Ellis LM; Gallick GE Cancer Res; 2005 May; 65(9):3664-70. PubMed ID: 15867361 [TBL] [Abstract][Full Text] [Related]
11. Targeting neuropilin-1 to inhibit VEGF signaling in cancer: Comparison of therapeutic approaches. Mac Gabhann F; Popel AS PLoS Comput Biol; 2006 Dec; 2(12):e180. PubMed ID: 17196035 [TBL] [Abstract][Full Text] [Related]
12. Targeting VEGF-neuropilin interactions: a promising antitumor strategy. Peng K; Bai Y; Zhu Q; Hu B; Xu Y Drug Discov Today; 2019 Feb; 24(2):656-664. PubMed ID: 30315890 [TBL] [Abstract][Full Text] [Related]
13. Vascular endothelial growth factor-trap suppresses tumorigenicity of multiple pancreatic cancer cell lines. Fukasawa M; Korc M Clin Cancer Res; 2004 May; 10(10):3327-32. PubMed ID: 15161686 [TBL] [Abstract][Full Text] [Related]
14. Inhibitory activity of ranibizumab, sorafenib, and pazopanib on light-induced overexpression of platelet-derived growth factor and vascular endothelial growth factor A and the vascular endothelial growth factor A receptors 1 and 2 and neuropilin 1 and 2. Kernt M; Thiele S; Neubauer AS; Koenig S; Hirneiss C; Haritoglou C; Ulbig MW; Kampik A Retina; 2012 Sep; 32(8):1652-63. PubMed ID: 22466477 [TBL] [Abstract][Full Text] [Related]
15. [Neuropilins: relevant therapeutic targets to improve the treatment of cancers]. Dumond A; Demange L; Pagès G Med Sci (Paris); 2020 May; 36(5):487-496. PubMed ID: 32452371 [TBL] [Abstract][Full Text] [Related]